Your browser doesn't support javascript.
loading
High BRAF variant allele frequencies are associated with distinct pathological features and responsiveness to target therapy in melanoma patients.
Berrino, E; Balsamo, A; Pisacane, A; Gallo, S; Becco, P; Miglio, U; Caravelli, D; Poletto, S; Paruzzo, L; Debernardi, C; Piccinelli, C; Zaccagna, A; Rescigno, P; Aglietta, M; Sapino, A; Carnevale-Schianca, F; Venesio, T.
Afiliación
  • Berrino E; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy; Department of Medical Sciences, University of Turin, Turin, Italy.
  • Balsamo A; Clinical Research Office, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy.
  • Pisacane A; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy.
  • Gallo S; Medical Oncology Division, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy.
  • Becco P; Medical Oncology Division, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy.
  • Miglio U; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy.
  • Caravelli D; Medical Oncology Division, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy.
  • Poletto S; Medical Oncology Division, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy; Department of Oncology, University of Turin, Turin, Italy.
  • Paruzzo L; Medical Oncology Division, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy; Department of Oncology, University of Turin, Turin, Italy.
  • Debernardi C; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy.
  • Piccinelli C; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy.
  • Zaccagna A; Dermosurgery, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy.
  • Rescigno P; Interdisciplinary Group for Research and Clinical Trials, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy.
  • Aglietta M; Medical Oncology Division, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy; Department of Oncology, University of Turin, Turin, Italy.
  • Sapino A; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy; Department of Medical Sciences, University of Turin, Turin, Italy. Electronic address: anna.sapino@ircc.it.
  • Carnevale-Schianca F; Medical Oncology Division, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy.
  • Venesio T; Pathology Unit, Candiolo Cancer Institute, FPO-IRCCs, Turin, Italy. Electronic address: tiziana.venesio@ircc.it.
ESMO Open ; 6(3): 100133, 2021 06.
Article en En | MEDLINE | ID: mdl-33984673
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: ESMO Open Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Melanoma Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: ESMO Open Año: 2021 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Reino Unido